Prognostic Stage IIA Breast Cancer AJCC v8 Completed Phase 1 Trials for Benzalkonium (DB11105)

Also known as: Prognostic Stage 2A Breast Cancer AJCC v8

DBCOND0109633 (Prognostic Stage IIA Breast Cancer AJCC v8)Completed1 IdentifierTitlePurposeDrugs
NCT04081389Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerTreatment